Shanghai GoBroad Cancer Hospital
Shanghai GoBroad Cancer Hospital is positioned as a clinical research public service platform, with strategic objectives focused on the diagnosis and treatment of complex oncological diseases, clinical research, and the industrial transformation of biopharmaceuticals and medical devices. The hospital has gathered nationally renowned clinical and research experts, along with a well-equipped, high-level clinical research support team. With clinical diagnostic and treatment capabilities as well as extensive clinical research expertise as the foundation, the hospital integrates resources from Shanghai's innovative pharmaceutical industry. It aims to create a research-oriented medical organization aligned with international standards, meeting the innovation needs of the Chinese biopharmaceutical industry. The hospital seeks to enhance the efficiency and quality of clinical research, promote innovation in the biopharmaceutical industry, and address unmet clinical needs.
Shanghai GoBroad Cancer Hospital is an explorer and practitioner of the research-oriented hospital model and is also one of the flagship hospitals of GoBroad Healthcare Group. Located in the Waigaoqiao area of Pudong New District, Shanghai, the hospital covers an approximate area of 60,000 square meters. The first phase of the hospital, with a planned total of 700 beds, is already operational with 400 open beds. The second phase is expected to commence operations in 2026.